MeSH D001437 - bacteriuria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alvogen | Methenamine hippurate | Urex | 1982-01-01 | |||
| Aurobindo Pharma | Methenamine hippurate | Methenamine Hippurate | 2016-07-05 | |||
| Impax Laboratories | Methenamine hippurate | Methenamine Hippurate | 2003-06-20 | |||
| Jubilant Therapeutics | Methenamine hippurate | Methenamine Hippurate | 2023-12-01 | |||
| Micro Laboratories | Methenamine hippurate | Methenamine Hippurate | 2019-08-01 | |||
| Novast Laboratories | Methenamine hippurate | Methenamine Hippurate | 2020-11-27 | |||
| Validus Pharmaceuticals | Methenamine hippurate | Hiprex | 1982-01-01 |
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
100%2/2
Phase 3
50%2/4
Approved: 2Overall Success rate: 33%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use